NUPHASE Trademark

Trademark Overview


On Wednesday, August 17, 2022, a trademark application was filed for NUPHASE with the United States Patent and Trademark Office. The USPTO has given the NUPHASE trademark a serial number of 97552581. The federal status of this trademark filing is REGISTERED as of Tuesday, April 9, 2024. This trademark is owned by Beijing NuPhase Therapeutics Co., Ltd.. The NUPHASE trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic preparations for medical purposes; medicines for the treatment of cancer, immune diseases, diseases affecting the central nervous system, and rare diseases; medicinal drinks; biochemical medicines for the treatment of cancer, immune diseases, diseases affecting the central nervous system, and rare diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer, immune diseases, diseases affecting the central nervous system, and rare diseases; pharmaceutical preparations for the treatment of cancer, immune diseases, diseases affecting the central nervous system, and rare diseases; biological tissue cultures for medical purposes; biological preparations for the treatment of cancer, immune diseases, diseases affecting the central nervous system, and rare diseases; reagent paper for medical purposes; nutraceutical preparations for therapeutic purposes or the treatment of cancer, immune diseases, diseases affecting the central nervous system, and ...
nuphase

General Information


Serial Number97552581
Word MarkNUPHASE
Filing DateWednesday, August 17, 2022
Status700 - REGISTERED
Status DateTuesday, April 9, 2024
Registration Number7350459
Registration DateTuesday, April 9, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2023

Trademark Statements


Goods and ServicesDiagnostic preparations for medical purposes; medicines for the treatment of cancer, immune diseases, diseases affecting the central nervous system, and rare diseases; medicinal drinks; biochemical medicines for the treatment of cancer, immune diseases, diseases affecting the central nervous system, and rare diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer, immune diseases, diseases affecting the central nervous system, and rare diseases; pharmaceutical preparations for the treatment of cancer, immune diseases, diseases affecting the central nervous system, and rare diseases; biological tissue cultures for medical purposes; biological preparations for the treatment of cancer, immune diseases, diseases affecting the central nervous system, and rare diseases; reagent paper for medical purposes; nutraceutical preparations for therapeutic purposes or the treatment of cancer, immune diseases, diseases affecting the central nervous system, and rare diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBeijing NuPhase Therapeutics Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDistrict, Beijing 100020
CN

Party NameBeijing NuPhase Therapeutics Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDistrict, Beijing 100020
CN

Party NameBeijing NuPhase Therapeutics Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDistrict, Beijing 100020
CN

Trademark Events


Event DateEvent Description
Tuesday, April 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, March 1, 20241(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, January 9, 2024NOTICE OF ALLOWANCE CANCELLED
Friday, March 1, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 9, 2024TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, December 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 6, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 6, 2023NON-FINAL ACTION E-MAILED
Tuesday, June 6, 2023NON-FINAL ACTION WRITTEN
Monday, June 5, 2023ASSIGNED TO EXAMINER
Friday, October 7, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, October 7, 2022ASSIGNED TO LIE
Saturday, August 27, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, September 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 20, 2022NEW APPLICATION ENTERED